161.57
price up icon0.53%   0.85
after-market Handel nachbörslich: 161.02 -0.55 -0.34%
loading
Schlusskurs vom Vortag:
$160.72
Offen:
$158
24-Stunden-Volumen:
1.09M
Relative Volume:
0.81
Marktkapitalisierung:
$22.56B
Einnahmen:
$1.53B
Nettoeinkommen (Verlust:
$-214.69M
KGV:
-91.80
EPS:
-1.76
Netto-Cashflow:
$-43.68M
1W Leistung:
-1.58%
1M Leistung:
+0.55%
6M Leistung:
+0.60%
1J Leistung:
+45.95%
1-Tages-Spanne:
Value
$158.00
$163.23
1-Wochen-Bereich:
Value
$158.00
$170.48
52-Wochen-Spanne:
Value
$92.14
$183.00

Natera Inc Stock (NTRA) Company Profile

Name
Firmenname
Natera Inc
Name
Telefon
650-249-9090
Name
Adresse
13011 MCCALLEN PASS, AUSTIN, CA
Name
Mitarbeiter
4,434
Name
Twitter
@nateragenetics
Name
Nächster Verdiensttermin
2024-11-12
Name
Neueste SEC-Einreichungen
Name
NTRA's Discussions on Twitter

Vergleichen Sie NTRA mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Diagnostics & Research icon
NTRA
Natera Inc
161.57 22.56B 1.53B -214.69M -43.68M -1.76
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
427.76 156.49B 42.90B 6.52B 6.72B 17.05
Diagnostics & Research icon
DHR
Danaher Corp
202.50 145.01B 23.82B 3.77B 4.90B 5.15
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
542.71 42.30B 3.93B 894.97M 837.70M 10.82
Diagnostics & Research icon
A
Agilent Technologies Inc
120.66 34.24B 6.63B 1.17B 1.19B 4.05
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
164.65 27.64B 15.50B 1.33B 2.16B 7.34

Natera Inc Stock (NTRA) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-03-13 Eingeleitet RBC Capital Mkts Outperform
2025-01-23 Eingeleitet Barclays Overweight
2024-06-03 Fortgesetzt Jefferies Buy
2024-04-08 Fortgesetzt Craig Hallum Buy
2024-02-20 Herabstufung Raymond James Strong Buy → Outperform
2023-12-29 Bestätigt BTIG Research Buy
2023-12-14 Eingeleitet Guggenheim Buy
2023-12-13 Eingeleitet Wolfe Research Outperform
2023-11-13 Hochstufung Raymond James Outperform → Strong Buy
2023-09-28 Eingeleitet Bernstein Mkt Perform
2023-07-05 Fortgesetzt JP Morgan Overweight
2023-05-05 Eingeleitet UBS Buy
2023-01-18 Hochstufung Raymond James Mkt Perform → Outperform
2022-08-25 Eingeleitet Credit Suisse Outperform
2022-04-25 Eingeleitet Stephens Overweight
2022-03-08 Eingeleitet Goldman Buy
2022-01-06 Fortgesetzt Piper Sandler Overweight
2021-10-15 Fortgesetzt Cowen Outperform
2021-06-15 Eingeleitet Raymond James Mkt Perform
2021-05-25 Eingeleitet Wells Fargo Overweight
2021-01-28 Eingeleitet Truist Buy
2020-10-08 Eingeleitet BTIG Research Buy
2020-09-28 Eingeleitet Morgan Stanley Overweight
2020-09-17 Eingeleitet SVB Leerink Outperform
2020-06-10 Fortgesetzt Piper Sandler Overweight
2020-05-07 Hochstufung JP Morgan Neutral → Overweight
2018-10-05 Eingeleitet JP Morgan Neutral
2018-07-05 Bestätigt Piper Jaffray Overweight
2017-08-07 Bestätigt Morgan Stanley Overweight
2016-11-10 Bestätigt The Benchmark Company Buy
2016-05-23 Bestätigt The Benchmark Company Buy
2016-05-11 Bestätigt The Benchmark Company Buy
2016-04-19 Eingeleitet The Benchmark Company Buy
2015-09-28 Hochstufung Wedbush Neutral → Outperform
2015-08-14 Hochstufung Morgan Stanley Equal-Weight → Overweight
2015-08-04 Eingeleitet Robert W. Baird Outperform
2015-07-27 Eingeleitet Morgan Stanley Equal-Weight
2015-07-27 Eingeleitet Piper Jaffray Overweight
2015-07-27 Eingeleitet Wedbush Neutral
Alle ansehen

Natera Inc Aktie (NTRA) Neueste Nachrichten

pulisher
Jun 18, 2025

Natera Approves Equity Plan Amendment at Annual Meeting - TipRanks

Jun 18, 2025
pulisher
Jun 18, 2025

DNA Testing Market Size, Share, and Forecast 2025-2033: Key - openPR.com

Jun 18, 2025
pulisher
Jun 17, 2025

Natera: Growth Likely To Moderate, Despite Signatera Test Medicare Coverage (NASDAQ:NTRA) - Seeking Alpha

Jun 17, 2025
pulisher
Jun 16, 2025

Non-Invasive Cancer Testing Market Forecast | Major Players: Guardant Health, Exact Sciences, Qiagen, Natera Inc. - openPR.com

Jun 16, 2025
pulisher
Jun 16, 2025

Where are the Opportunities in (NTRA) - news.stocktradersdaily.com

Jun 16, 2025
pulisher
Jun 13, 2025

Here's How Much You Would Have Made Owning Natera Stock In The Last 10 Years - Benzinga

Jun 13, 2025
pulisher
Jun 12, 2025

Insider Sell: Gail Marcus Sells 4,000 Shares of Natera Inc (NTRA) - GuruFocus

Jun 12, 2025
pulisher
Jun 12, 2025

Molecular Diagnostics for Cancer Market Research 2025: Advances in Personalized Medicine and Liquid Biopsies Reshape Industry Landscape - GlobeNewswire Inc.

Jun 12, 2025
pulisher
Jun 10, 2025

NTRA Q1 Earnings Call: Growth in Oncology and Women's Health Drives Guidance Increase - Yahoo Finance

Jun 10, 2025
pulisher
Jun 10, 2025

Transcript : Natera, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-09-2025 02 - MarketScreener

Jun 10, 2025
pulisher
Jun 10, 2025

Prenatal Genetic Counselling Market 2025-2032: Top Trends & - openPR.com

Jun 10, 2025
pulisher
Jun 09, 2025

Natera at Goldman Sachs Conference: Strategic Growth and Expansion - Investing.com Australia

Jun 09, 2025
pulisher
Jun 09, 2025

Natera at Goldman Sachs Conference: Strategic Growth and Expansion By Investing.com - Investing.com India

Jun 09, 2025
pulisher
Jun 05, 2025

Insider Sell: Steven Chapman Sells Shares of Natera Inc (NTRA) - GuruFocus

Jun 05, 2025
pulisher
Jun 05, 2025

Colorectal Cancer Diagnostics Market Size To Boom with Top Key - openPR.com

Jun 05, 2025
pulisher
Jun 05, 2025

Natera stock gains after Leerink Partners reiterates outperform rating By Investing.com - Investing.com South Africa

Jun 05, 2025
pulisher
Jun 05, 2025

Natera's Signatera test to be covered under Medicare - MSN

Jun 05, 2025
pulisher
Jun 04, 2025

Medicare expands coverage for Natera’s Signatera MRD test By Investing.com - Investing.com South Africa

Jun 04, 2025
pulisher
Jun 04, 2025

Sector Update: Health Care - marketscreener.com

Jun 04, 2025
pulisher
Jun 04, 2025

Natera Inc (NTRA) Trading 4.28% Higher on Jun 4 - GuruFocus

Jun 04, 2025
pulisher
Jun 04, 2025

Natera (NTRA) Gains Medicare Coverage for Genome-Based Cancer Te - GuruFocus

Jun 04, 2025
pulisher
Jun 04, 2025

Natera stock gains after Leerink Partners reiterates outperform rating - Investing.com

Jun 04, 2025
pulisher
Jun 04, 2025

Natera's Signatera test to be covered under Medicare (NTRA:NASDAQ) - Seeking Alpha

Jun 04, 2025
pulisher
Jun 04, 2025

Natera, Inc. Announces Medicare Coverage for Signatera Genome - marketscreener.com

Jun 04, 2025
pulisher
Jun 04, 2025

Natera (NTRA) Secures Medicare Coverage for Signatera MRD Assay | NTRA Stock News - GuruFocus

Jun 04, 2025
pulisher
Jun 04, 2025

Natera announces Medicare coverage for Signatera MRD assay - TipRanks

Jun 04, 2025
pulisher
Jun 04, 2025

Medicare expands coverage for Natera’s Signatera MRD test - Investing.com Australia

Jun 04, 2025
pulisher
Jun 04, 2025

Natera Announces Medicare Coverage for Signatera™ Genome | NTRA Stock News - GuruFocus

Jun 04, 2025
pulisher
Jun 04, 2025

Natera Announces Medicare Coverage for Signatera ™ Genome - Business Wire

Jun 04, 2025
pulisher
Jun 04, 2025

Natera Announces Medicare Coverage for Signatera™ Genome - New Castle News

Jun 04, 2025
pulisher
Jun 03, 2025

Natera (NasdaqGS:NTRA) Showcases 94% Sensitivity In Pan-Cancer Signatera Genome Study - simplywall.st

Jun 03, 2025
pulisher
Jun 02, 2025

SignateraTM Genome Clinical Performance Highlighted at ASCO 2025 - GuruFocus

Jun 02, 2025
pulisher
May 31, 2025

Natera Inc.: Is The Recent Growth in Signatera Volumes Here To Stay? - Smartkarma

May 31, 2025
pulisher
May 27, 2025

Natera Inc (NTRA) Shares Up 3.07% on May 27 - GuruFocus

May 27, 2025
pulisher
May 26, 2025

If You Invested $100 In This Stock 5 Years Ago, You Would Have This Much Today - Benzinga

May 26, 2025
pulisher
May 24, 2025

When the Price of (NTRA) Talks, People Listen - news.stocktradersdaily.com

May 24, 2025
pulisher
May 23, 2025

Natera Reaches 80-Plus Relative Strength Rating Benchmark - Investor's Business Daily

May 23, 2025
pulisher
May 22, 2025

Natera to Present over 25 Signatera™ Studies at 2025 ASCO Annual Meeting | NTRA Stock News - GuruFocus

May 22, 2025
pulisher
May 22, 2025

Natera to Present over 25 Signatera™ Studies at 2025 ASCO Annual Meeting - Yahoo Finance

May 22, 2025
pulisher
May 22, 2025

Natera raises 2025 revenue outlook to $1.94B-$2.02B with 26% growth target - MSN

May 22, 2025
pulisher
May 22, 2025

Transcript : Natera, Inc. Presents at RBC Capital Markets Global Healthcare Conference 2025, May-21-2025 10 - marketscreener.com

May 22, 2025
pulisher
May 19, 2025

Natera (NTRA) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates - MSN

May 19, 2025
pulisher
May 19, 2025

Stocks Showing Rising Market Leadership: Natera Earns 82 RS Rating - Investor's Business Daily

May 19, 2025
pulisher
May 18, 2025

There's Reason For Concern Over Natera, Inc.'s (NASDAQ:NTRA) Price - simplywall.st

May 18, 2025
pulisher
May 17, 2025

Natera (NASDAQ:NTRA) Rating Lowered to “Sell” at StockNews.com - Defense World

May 17, 2025
pulisher
May 17, 2025

Natera (NASDAQ:NTRA) Stock Price Expected to Rise, Piper Sandler Analyst Says - Defense World

May 17, 2025
pulisher
May 16, 2025

Natera: The Clues In Q1 Earnings (NASDAQ:NTRA) - Seeking Alpha

May 16, 2025
pulisher
May 15, 2025

NTRA: Piper Sandler Raises Price Target for Natera | NTRA Stock News - GuruFocus

May 15, 2025

Finanzdaten der Natera Inc-Aktie (NTRA)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
diagnostics_research LH
$260.00
price down icon 1.61%
diagnostics_research WAT
$351.92
price down icon 1.43%
diagnostics_research MTD
$1,205.65
price up icon 0.03%
diagnostics_research DGX
$176.60
price down icon 1.52%
diagnostics_research IQV
$164.65
price up icon 1.25%
Kapitalisierung:     |  Volumen (24h):